Medicxi Entities Fully Exit Position in Centessa Pharmaceuticals plc (CNTA)

Medicxi Growth I LP, along with several affiliated Jersey-based entities including Medicxi Ventures I LP and Medicxi Secondary I LP, filed a Schedule 13G/A on August 4, 2026, regarding their holdings in Centessa Pharmaceuticals plc (CNTA). The filing, which serves as Amendment No. 2, reports that as of June 30, 2026, the reporting persons have fully exited their position in the company. The group of reporting persons, managed by Medicxi Ventures Management (Jersey) Limited, now beneficially owns zero ordinary shares, representing a 0.0% ownership stake. This is a significant decrease from previous filings where the group held a reportable interest. The reporting entities include various limited partnerships and their respective general partners, all based in Jersey. The filing confirms that the reporting persons no longer have any voting or dispositive power over the issuer's securities, effectively concluding their status as major shareholders in Centessa Pharmaceuticals.